Finished
Powered Assist to Improve Ambulation in Severe Lung Disease
NCT03790644 · West Park Healthcare Centre · Updated 4 May 2022
- What is being tested
- exoskeleton assist
- For
- Lung Disease Chronic
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 6 people. The full rules are on the registry page.
- Where
- Canada
- When
- Starts or started 1 Aug 2018, ends 30 May 2021. Registered 31 Dec 2018.
- Results
- None posted yet.
In the researchers' words
Chronic respiratory disease (CRD) is among the most prevalent and growing diseases worldwide with disabling consequences. Many with a compromised respiratory system cannot support the metabolic energy demands of walking causing them to walk slowly and stop often. Those with CRD could receive substantial benefit from a powered wearable exoskeleton device that assumes part of the energy of walking. Assisting the legs will lower the metabolic energy demands, and therefore the ventilation required for exercise, thereby allowing them to walk faster and further. Proposed is a series of single-case experiments comparing walking endurance with and without a powered exoskeleton assist. The aim of this study is to determine the efficacy of an exoskeleton on walking endurance in ventilatory limited patients with CRD. An exoskeleton could be a novel immediate and long term strategy to augment walking as part of the spectrum of pulmonary rehabilitation and community reintegration.
Sites
- Westpark Health Care CentreToronto, Ontario, Canada
